This suggest that the inhibition of DHODH can be used as a sequential step after TMZ treatment and not necessarily in combination with it, indicating that it could become an alternative approach to treat glioblastoma patients that develop TMZ resistance. This evidence concerns the gene DHODH and glioblastoma.